Literature DB >> 9006926

A novel reaction mechanism for the formation of S-nitrosothiol in vivo.

A J Gow1, D G Buerk, H Ischiropoulos.   

Abstract

The objective of this study was to investigate the mechanism of S-nitrosothiol formation under physiological conditions. A mechanism is proposed by which nitric oxide (.NO) reacts directly with reduced thiol to produce a radical intermediate, R-S-N.-O-H. This intermediate reduces an electron acceptor to produce S-nitrosothiol. Under aerobic conditions O2 acts as the electron acceptor and is reduced to produce superoxide (O-2). The following experimental evidence is provided in support of this mechanism. Cysteine accelerates the consumption of .NO by 2.5-fold under physiological conditions. The consumption of O2 in the presence of .NO and cysteine is increased by 2.4-fold. The reaction orders of .NO and cysteine are second and first order, respectively. The second order of reaction for .NO may result from interaction between .NO and O-2 to form peroxynitrite. In the presence of Cu,Zn-superoxide dismutase, the reaction of .NO with cysteine generates hydrogen peroxide, indicating that the reaction generates O-2. Finally, the formation of S-nitrosothiol is demonstrated in an anaerobic environment and, as predicted by the mechanism, is dependent on the presence of an electron acceptor. These results demonstrate that under physiological conditions .NO reacts directly with thiols to form S-nitrosothiol in the presence of an electron acceptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9006926     DOI: 10.1074/jbc.272.5.2841

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Evidence for in vivo transport of bioactive nitric oxide in human plasma.

Authors:  Tienush Rassaf; Michael Preik; Petra Kleinbongard; Thomas Lauer; Christian Heiss; Bodo-Eckehard Strauer; Martin Feelisch; Malte Kelm
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 2.  Routes for formation of S-nitrosothiols in blood.

Authors:  Enika Nagababu; Joseph M Rifkind
Journal:  Cell Biochem Biophys       Date:  2013-11       Impact factor: 2.194

3.  Cytochrome c-mediated formation of S-nitrosothiol in cells.

Authors:  Katarzyna A Broniowska; Agnes Keszler; Swati Basu; Daniel B Kim-Shapiro; Neil Hogg
Journal:  Biochem J       Date:  2012-02-15       Impact factor: 3.857

4.  An autocatalytic mechanism of protein nitrosylation.

Authors:  A Nedospasov; R Rafikov; N Beda; E Nudler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

5.  Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo.

Authors:  Nathan S Bryan; Tienush Rassaf; Ronald E Maloney; Cynthia M Rodriguez; Fumito Saijo; Juan R Rodriguez; Martin Feelisch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-10       Impact factor: 11.205

Review 6.  NO/redox disequilibrium in the failing heart and cardiovascular system.

Authors:  Joshua M Hare; Jonathan S Stamler
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 7.  Proteomic methods for analysis of S-nitrosation.

Authors:  Nicholas J Kettenhofen; Katarzyna A Broniowska; Agnes Keszler; Yanhong Zhang; Neil Hogg
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-02-25       Impact factor: 3.205

Review 8.  Redox signaling.

Authors:  Henry Jay Forman; Martine Torres; Jon Fukuto
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

9.  The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A.

Authors:  Philip O'Reilly; Judy M Hickman-Davis; Philip McArdle; K Randall Young; Sadis Matalon
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

10.  A nitric oxide/cysteine interaction mediates the activation of soluble guanylate cyclase.

Authors:  Nathaniel B Fernhoff; Emily R Derbyshire; Michael A Marletta
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.